311 related articles for article (PubMed ID: 24641506)
1. Analgesic synergy between opioid and α2 -adrenoceptors.
Chabot-Doré AJ; Schuster DJ; Stone LS; Wilcox GL
Br J Pharmacol; 2015 Jan; 172(2):388-402. PubMed ID: 24641506
[TBL] [Abstract][Full Text] [Related]
2. Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.
Schuster DJ; Metcalf MD; Kitto KF; Messing RO; Fairbanks CA; Wilcox GL
Br J Pharmacol; 2015 Jan; 172(2):642-53. PubMed ID: 24827408
[TBL] [Abstract][Full Text] [Related]
3. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.
Stone LS; MacMillan LB; Kitto KF; Limbird LE; Wilcox GL
J Neurosci; 1997 Sep; 17(18):7157-65. PubMed ID: 9278550
[TBL] [Abstract][Full Text] [Related]
4. Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.
Chabot-Doré AJ; Millecamps M; Naso L; Devost D; Trieu P; Piltonen M; Diatchenko L; Fairbanks CA; Wilcox GL; Hébert TE; Stone LS
Neuropharmacology; 2015 Dec; 99():285-300. PubMed ID: 26254859
[TBL] [Abstract][Full Text] [Related]
5. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Tham SM; Angus JA; Tudor EM; Wright CE
Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord.
Overland AC; Kitto KF; Chabot-Doré AJ; Rothwell PE; Fairbanks CA; Stone LS; Wilcox GL
J Neurosci; 2009 Oct; 29(42):13264-73. PubMed ID: 19846714
[TBL] [Abstract][Full Text] [Related]
7. alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy.
Fairbanks CA; Stone LS; Kitto KF; Nguyen HO; Posthumus IJ; Wilcox GL
J Pharmacol Exp Ther; 2002 Jan; 300(1):282-90. PubMed ID: 11752127
[TBL] [Abstract][Full Text] [Related]
8. The delta-opioid receptor is sufficient, but not necessary, for spinal opioid-adrenergic analgesic synergy.
Chabot-Doré AJ; Millecamps M; Stone LS
J Pharmacol Exp Ther; 2013 Dec; 347(3):773-80. PubMed ID: 24039246
[TBL] [Abstract][Full Text] [Related]
9. ST91 [2-(2,6-diethylphenylamino)-2-imidazoline hydrochloride]-mediated spinal antinociception and synergy with opioids persists in the absence of functional alpha-2A- or alpha-2C-adrenergic receptors.
Stone LS; Kitto KF; Eisenach JC; Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 2007 Dec; 323(3):899-906. PubMed ID: 17855473
[TBL] [Abstract][Full Text] [Related]
10. Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects.
Stone LS; German JP; Kitto KF; Fairbanks CA; Wilcox GL
PLoS One; 2014; 9(10):e109903. PubMed ID: 25299457
[TBL] [Abstract][Full Text] [Related]
11. Interaction of morphine with a new alpha2-adrenoceptor agonist in mice.
Sudo RT; Calasans-Maia JA; Galdino SL; Lima MC; Zapata-Sudo G; Hernandes MZ; Pitta IR
J Pain; 2010 Jan; 11(1):71-8. PubMed ID: 19853523
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions.
Ruuskanen JO; Peitsaro N; Kaslin JV; Panula P; Scheinin M
J Neurochem; 2005 Sep; 94(6):1559-69. PubMed ID: 16000146
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between alpha2-adrenoceptors, mu- and kappa-opioid receptors in the guinea pig myenteric plexus: effect of chronic desipramine treatment.
Canciani L; Giaroni C; Zanetti E; Giuliani D; Pisani R; Moro E; Trinchera M; Crema F; Lecchini S; Frigo G
Eur J Pharmacol; 2006 Dec; 553(1-3):269-79. PubMed ID: 17055479
[TBL] [Abstract][Full Text] [Related]
14. Spinal α
Bahari Z; Meftahi GH
Br J Pharmacol; 2019 Jul; 176(14):2366-2381. PubMed ID: 30657594
[TBL] [Abstract][Full Text] [Related]
15. Interaction of morphine but not fentanyl with cerebral alpha2-adrenoceptors in alpha2-adrenoceptor knockout mice.
Höcker J; Böhm R; Meybohm P; Gruenewald M; Renner J; Ohnesorge H; Scholz J; Bein B
J Pharm Pharmacol; 2009 Jul; 61(7):901-10. PubMed ID: 19589232
[TBL] [Abstract][Full Text] [Related]
16. Moxonidine, a mixed alpha(2)-adrenergic and imidazoline receptor agonist, identifies a novel adrenergic target for spinal analgesia.
Stone LS; Fairbanks CA; Wilcox GL
Ann N Y Acad Sci; 2003 Dec; 1009():378-85. PubMed ID: 15028616
[TBL] [Abstract][Full Text] [Related]
17. Supraspinal and spinal delta(2) opioid receptor-mediated antinociceptive synergy is mediated by spinal alpha(2) adrenoceptors.
Grabow TS; Hurley RW; Banfor PN; Hammond DL
Pain; 1999 Oct; 83(1):47-55. PubMed ID: 10506671
[TBL] [Abstract][Full Text] [Related]
18. Opioid receptor trafficking and interaction in nociceptors.
Zhang X; Bao L; Li S
Br J Pharmacol; 2015 Jan; 172(2):364-74. PubMed ID: 24611685
[TBL] [Abstract][Full Text] [Related]
19. The analgesic efficacy of partial opioid agonists is increased in mice with targeted inactivation of the alpha2A-adrenoceptor gene.
Ozdoğan UK; Lähdesmäki J; Scheinin M
Eur J Pharmacol; 2006 Jan; 529(1-3):105-13. PubMed ID: 16325800
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats.
Meert TF; De Kock M
Anesthesiology; 1994 Sep; 81(3):677-88. PubMed ID: 7916547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
